Access to anti-retroviral drugs, female in Morocco
Morocco: Access to anti-retroviral drugs, female was 93.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Morocco, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Morocco stood at 93.0%. That is the highest value across all 25 years on record.
That represents a change of up 3.3% on the previous year and up 151.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Morocco peaked at 93.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Morocco 22nd out of 141 countries with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Morocco, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 4.0% | — |
| 2004 | 6.0% | +50.0% |
| 2005 | 7.0% | +16.7% |
| 2006 | 8.0% | +14.3% |
| 2007 | 9.0% | +12.5% |
| 2008 | 12.0% | +33.3% |
| 2009 | 14.0% | +16.7% |
| 2010 | 16.0% | +14.3% |
| 2011 | 20.0% | +25.0% |
| 2012 | 27.0% | +35.0% |
| 2013 | 33.0% | +22.2% |
| 2014 | 37.0% | +12.1% |
| 2015 | 41.0% | +10.8% |
| 2016 | 46.0% | +12.2% |
| 2017 | 50.0% | +8.7% |
| 2018 | 54.0% | +8.0% |
| 2019 | 59.0% | +9.3% |
| 2020 | 63.0% | +6.8% |
| 2021 | 81.0% | +28.6% |
| 2022 | 84.0% | +3.7% |
| 2023 | 90.0% | +7.1% |
| 2024 | 93.0% | +3.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.0% | 0.0% | 14.0% | 10 |
| 2010s | 38.3% | 16.0% | 59.0% | 10 |
| 2020s | 82.2% | 63.0% | 93.0% | 5 |
Countries ranked near Morocco
- 19 Cameroon 95.0% compare
- 19 Sierra Leone 95.0% compare
- 19 Tajikistan 95.0% compare
- 22 France 93.0% compare
- 22 Malawi 93.0% compare
- 25 Denmark 91.0% compare
- 25 Saudi Arabia 91.0% compare
More gender data for Morocco
- Child population (UN estimates and projections) 9,271 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.8062 % change on previous year (2030)
- Population 30,683 (2030)
- Working-age population (UN estimates and projections) 30,683 (2030)
- Population (UN estimates and projections), annual growth rate 1.17 % change on previous year (2030)
- Age population, age 00, female, interpolated 299,791 (2025)
- Age population, age 00, male, interpolated 313,075 (2025)
- Age population, age 01, female, interpolated 301,405 (2025)
- Age population, age 01, male, interpolated 314,719 (2025)
- Age population, age 02, female, interpolated 303,515 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Morocco?
- Access to anti-retroviral drugs, female in Morocco was 93.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Morocco?
- The highest recorded value was 93.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Morocco?
- The lowest recorded value was 0.0% in 2000.
- How does Morocco rank for access to anti-retroviral drugs, female?
- Morocco ranks 22nd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Morocco?
- Over the last ten years it is up 151.4%. The long-run trend across the full record is volatile.
- Where does this Morocco data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.